RadNet account plan
Diagnostic imaging services
At a glance
RadNet runs 439 US outpatient diagnostic imaging centers and the DeepHealth radiology AI business, with 2025 revenue of $2,040.2 million.
RadNet operates freestanding, multi-modality outpatient diagnostic imaging centers (MRI, CT, PET, mammography, ultrasound, X-ray), directly or through joint ventures with hospitals and health systems, and sells AI-powered radiology software through its Digital Health segment, DeepHealth. At September 30, 2026 it ran 439 centers in Arizona, California, Delaware, Florida, Idaho, Indiana, Maryland, New Jersey, New York, Texas and Virginia, plus UK teleradiology through HLH Imaging. In 2025 total revenue was $2,040.2 million, Adjusted EBITDA $300.2 million and the net loss attributable to RadNet $18.7 million. At year-end 2025 it had 8,844 full-time, 432 part-time and 1,988 per diem employees including its contracted medical group. In business since 1985, it is led by founder Dr. Howard G. Berger, President and CEO.
Business units
Imaging Centers
$1,988.2 million 2025 segment revenueOutpatient imaging centers paid by commercial insurers, Medicare, Medicaid and capitation, growing through tuck-in acquisitions, de novo sites and health-system joint ventures (161 of 439 centers). Q3 2026 revenue rose 21.4% to $617.0 million with same-center revenue up 9.6%, driven by advanced imaging such as PET/CT for prostate cancer and Alzheimer's studies.
Digital Health (DeepHealth)
$92.7 million 2025 segment revenueAI-powered radiology informatics (RIS, PACS and Clinical AI for breast, prostate, lung, thyroid and brain) on the cloud-native DeepHealth OS, sold to RadNet and 3,070 customers. Q3 2026 revenue rose 32.6% to $32.9 million and ARR reached $112.6 million; led by Kees Wesdorp, President and CEO of Digital Health.
Strategic priorities
- Health-system joint ventures
- Expand partnerships with hospital systems, which now hold about 37% of centers; the Maryland Imaging Partners venture with the University of Maryland Medical System (19 locations) was formed on August 1, 2026.
- Advanced imaging and capacity
- Create and fill capacity at existing centers and shift mix to MRI, CT and PET/CT; advanced imaging rose to 30.6% of volume in Q3 2026, and about 10 de novo sites open in 2026.
- Cloud First, AI Powered
- Grow DeepHealth by penetrating existing accounts, expanding internationally and selling DeepHealth OS enterprise-wide, targeting ARR above $140 million at year-end 2026.
- AI inside RadNet
- Deploy Reporting Pro network-wide by Q1 2027, clinical AI on over 75% of exams by Q3 2027, draft X-ray reporting, remote technologists and digital patient registration.
- Radiology professional services
- The ONRAD acquisition will form a third segment, Radiology Professional Services, using a land and shift approach that brings hospital radiology departments onto DeepHealth tools.
Latest results
In Q3 2026 total service revenue was $638.3 million versus $522.9 million a year earlier, and Adjusted EBITDA rose to $105.0 million from $84.9 million; net income attributable to RadNet was $4.2 million. Imaging volumes grew 19.9% in aggregate and 8.9% same-center. Digital Health booked a record quarter of about $71 million total contract value but posted a segment loss as acquisitions were integrated. Imaging Center 2026 guidance was raised to revenue of $2.385-2.435 billion and Adjusted EBITDA of $350-363 million, and Digital Health guidance is revenue of $135-145 million.
Investments and deals
- ONRAD acquisition
- Merger agreement signed October 26, 2026 for $350 million cash plus 5 million RadNet shares and an earn-out of up to $210 million; ONRAD serves more than 225 hospitals in 26 states and closing is expected in Q1 2027.
- Gleamer acquisition
- Paris-based radiology AI company Gleamer was acquired on March 2, 2026 for about $264.1 million, with more than 700 customer contracts in 44 countries.
- 2026 imaging center acquisitions
- Regional Radiology Center (13 Florida centers), Northwest Radiology Network (Indiana), Intermountain Medical Imaging (Idaho) and two Maryland groups, for aggregate consideration of $107.2 million in the nine months.
- 2025 Digital Health deals
- See-Mode (about $28.9 million), iCAD (about $110.7 million, all-stock) and CIMAR UK (about $37.0 million) in 2025.
- Equipment and capex
- 2025 capex was $213.3 million, and 2026 Imaging Center capex is guided at $170-180 million; legacy units are being replaced with AI-enabled equipment.
Challenges and risks
- Radiologist and technologist shortages
- Shortages are acute and expected to continue, which RadNet addresses with AI productivity tools and remote technologists.
- Reimbursement pressure
- Medicare is about 25% of the business; the 2027 final rule cuts the conversion factor about 2.3%, an estimated $5 million revenue impact.
- Labor cost inflation
- 2026 guidance embeds over $30 million of same-center labor increases, after California's minimum-wage mandate raised costs from 2025.
- Digital Health losses during integration
- Digital Health is expected to keep operating at a net loss in the near term while iCAD, See-Mode, CIMAR and Gleamer are integrated; implementation capacity is a stated headwind.
- Regulation and cybersecurity
- The business faces extensive healthcare regulation, FDA oversight of software as medical devices, and cybersecurity and ransomware risks.
What leadership says
“RadNet is here for the long haul.”
“land and expand, not build and hold”
“the strongest quarter in the company's history”
Where a supplier can help
- Workforce and productivity tools
- Radiologist and technologist shortages and over $30 million of labor increases make staffing, scheduling and remote-operations solutions relevant to the AI inside RadNet priority.
- Integration of acquisitions
- ONRAD, Gleamer and a steady flow of center acquisitions need IT integration, cloud migration of iCAD customers and implementation capacity, a named Digital Health headwind.
- Cloud and infrastructure for DeepHealth
- Digital Health costs rise with software and cloud computing as ARR grows; cloud, security and data platform vendors fit the Cloud First, AI Powered priority.
- Equipment and isotopes for advanced imaging
- Growth in PET/CT, MRI and CT, new de novo sites and AI-enabled equipment replacement drive demand for imaging equipment, service and tracer supply.
- Revenue cycle and patient access
- Reimbursement pressure and digital self-registration rollouts open room for billing, revenue cycle and patient engagement solutions.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like RadNet?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- RadNet, Inc. Annual Report on Form 10-K for the fiscal year ended December 31, 2025
- RadNet is the largest operator of freestanding, fixed-site outpatient diagnostic imaging centers in the US: 418 centers at December 31, 2025 (398 in 2024, 366 in 2023) in Arizona, California, Delaware, Florida, Maryland, Virginia, New Jersey, New York and Texas, plus UK teleradiology through HLH Imaging.
- FY2025 total revenue was $2,040.2 million (2024: $1,829.7 million); Adjusted EBITDA $300.2 million (2024: $279.5 million); net loss attributable to RadNet of $18.7 million (2024: net income of $2.8 million).
- Two segments: Imaging Center (revenue $1,988.2 million, up 10.9%; Adjusted EBITDA $284.7 million) and Digital Health / DeepHealth (revenue $92.7 million, up 41.1%; Adjusted EBITDA $15.5 million; segment net loss $30.3 million).
- Digital Health is an AI and imaging-informatics business (DeepHealth OS, eRad RIS/PACS, Clinical AI for breast, prostate, lung, thyroid and brain) with 22 FDA clearances and 15 CE marks, ARR of $75 million at end-2025 and a customer base that grew from 486 to 2,075, mostly through the iCAD acquisition.
- 2025 acquisitions: 11 imaging-center asset acquisitions for $133.1 million total consideration, plus See-Mode ($28.9 million), iCAD (all-stock, about $110.7 million) and CIMAR UK (about $37.0 million) in Digital Health.
- Advanced imaging (MRI, CT, PET/CT) drove growth; PET/CT for prostate cancer and Alzheimer's studies was a significant contributor; medical supplies rose 22.2% on high-cost isotope tracers.
- Payor mix: Medicare about 23.4% and Medicaid 2.5% of imaging-center net service revenue; capitation about 6% of total net revenue.
- Balance sheet: $767.2 million cash, $1,072.6 million term-loan debt, undrawn $282.0 million Barclays and $50.0 million Truist revolvers; capex $213.3 million in 2025.
- Key risks: reimbursement cuts (CY2026 Medicare Physician Fee Schedule), labor costs and radiologist shortages (including California's healthcare minimum wage), dependence on contracted radiology groups and physician referrals, cybersecurity/ransomware, integration of acquisitions.
- Workforce: 8,844 full-time, 432 part-time and 1,988 per diem employees including the Group; led by Dr. Howard G. Berger (President and CEO) and Mark D. Stolper (CFO).
- RadNet, Inc. Quarterly Report on Form 10-Q for the quarter ended September 30, 2026
- Q3 2026 total service revenue was $638.3 million, up from $522.9 million; nine-month revenue $1,836.6 million versus $1,492.5 million.
- Q3 Adjusted EBITDA $105.0 million (Imaging Center $102.0 million, Digital Health $3.0 million); net income attributable to RadNet $4.2 million in Q3, nine-month net loss $21.8 million.
- 439 centers at September 30, 2026 in 11 states (Idaho and Indiana added); 161 held in health-system joint ventures.
- Imaging Center Q3 revenue up 21.4% to $617.0 million, same-center up 9.6%; systemwide MR volumes up 18.3%, CT 22.0%, PET/CT 30.4%.
- 2026 Imaging Center acquisitions for $107.2 million: Regional Radiology Center (13 Florida centers), Northwest Radiology Network (6 in Indiana), Intermountain Medical Imaging (5 in Idaho), St. Joseph and BWI (Maryland); Maryland Imaging Partners formed with UMMS (80% RadNet).
- Digital Health Q3 revenue up 32.6% to $32.9 million; ARR $112.6 million (vs $67.3 million); 3,070 customers; Gleamer acquired March 2, 2026 for about $264.1 million.
- Digital Health operating loss of $22.4 million in Q3; the segment is expected to stay loss-making near term during integration.
- ONRAD merger agreement (October 26, 2026): $350 million cash plus 5 million shares, earn-out up to $210 million on 2027 EBITDA; closing expected Q1 2027.
- $250.0 million incremental term loan in June 2026; term loans $1,317.8 million face; cash $750.6 million.
- RadNet Q3 2026 earnings call transcript
- Record Q3: revenue up 22.1% to about $638 million and Adjusted EBITDA up 23.8% to $105 million; imaging volumes up 19.9% aggregate and 8.9% same-center.
- Advanced imaging rose from 28.2% to 30.6% of procedural volume; Imaging Center Adjusted EBITDA up 25.3%.
- ONRAD (130+ contracted radiologists, 225+ hospitals in 26 states) expected to add $190-200 million revenue and $60-65 million Adjusted EBITDA in year one and to become a third segment, Radiology Professional Services.
- 2026 Imaging Center guidance raised to $2.385-2.435 billion revenue and $350-363 million Adjusted EBITDA; free cash flow $120-130 million.
- DeepHealth: about $71 million total contract value closed in Q3 including a ~$53 million teleradiology enterprise deal; pipeline above $300 million; ARR $112.6 million, target above $140 million by year-end.
- AI deployment inside RadNet: Reporting Pro covers over 30% of exams, clinical AI over 50%, Gleamer X-ray AI live; goal of over 50% report automation by Q3 2027.
- Medicare final rule for 2027 estimated to cost about $5 million of revenue; Berger frames the mission as shifting care to early diagnosis and prevention.
- RadNet Q4 and full-year 2025 earnings call transcript (Gleamer acquisition)
- Q4 2025 was RadNet's strongest quarter: revenue up 14.8% to $547.7 million and Adjusted EBITDA up 16.9% to $87.7 million; Digital Health Q4 revenue up 48.2% to $27.9 million.
- Advanced imaging (MRI, CT, PET/CT) is responsible for over 60% of revenue; Q4 advanced volumes up 14.1% aggregate and 9.6% same-center.
- 151 of 418 centers (36.1%) in health-system partnerships; seven de novos opened in 2025; Southwest Florida (13 centers) and Indiana (6) acquired in January 2026.
- Gleamer (Paris) acquired for up to EUR 230 million: 700+ customer contracts in 44 countries, about $30 million ARR expected in 2026, EBITDA positive by mid-2027.
- 2026 guidance: Imaging Center revenue growth 17-19%, free cash flow growth 29-41%, Digital Health revenue growth 45-55%, ARR approaching $140 million (from $75.4 million).
- Headwinds: over $30 million (about 4%) of same-center labor increases and winter weather in Q1.
- Berger: AI in healthcare is about making an insufficient workforce more productive, not replacing people; hospitals' inbound calls have dramatically increased.
Questions about RadNet
What does RadNet do?
RadNet operates outpatient diagnostic imaging centers in the US, often with hospital joint ventures, and sells AI-powered radiology software through DeepHealth.
What is RadNet's revenue?
Total revenue was $2,040.2 million in 2025; Imaging Center 2026 revenue is guided at $2.385-2.435 billion.
How many employees does RadNet have?
At year-end 2025 RadNet had 8,844 full-time, 432 part-time and 1,988 per diem employees, including its contracted medical group.
Who leads RadNet?
Dr. Howard G. Berger is President and CEO, Mark D. Stolper is CFO and Kees Wesdorp leads Digital Health.
What is RadNet's strategy?
Grow imaging capacity and advanced imaging, expand health-system joint ventures and acquisitions, and build DeepHealth as a cloud-first, AI-powered radiology platform used inside and outside RadNet.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)